Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic agents comprising nucleic acids and CAR-modified immune cells, and uses thereof

Therapeutic agents comprising nucleic acids and CAR-modified immune cells, and uses thereof

US Patent 12329826 · Granted Jun 17, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lower rotor assemblies for torque sensors2025
Birdstrike avoidance optical flexible film, preparation method and application t2025
Degradable regenerative medical material for promoting tissue in-situ regenerati2025
Drug-loaded mesoporous silica nanoparticle for prevention and treatment of brain2025
Method for delivering an agent to posterior segment of an eye and uses thereof2024
Therapeutic agents comprising nucleic acids and TCR modified immune cells and us2023
Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and us2023
Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and us2023
Therapeutic compositions and applications that comprise nucleic acids and adopti2023
Therapeutic compositions and applications that comprise nucleic acids and adopti2023
Use of bromophenol-pyrazoline compounds in the treatment of porcine coronavirus 2023
Vehicle headlight2023